DistillerSR Blog

Collecting, evaluating and managing evidence is the most crucial part of research that drives...

In a recent interview to Medical Alley, Peter O’Blenis, CEO at DistillerSR, discussed the company's...

Public sector and not-for-profit research is informing critical guidelines and regulations that...

In our most recent webinar, DistillerSR customers Monique Liston, Senior Medical Writer at NuVasive...

The publication of the original PRISMA (Preferred Reporting Items for Systematic reviews and...

At our recent webinar, we were joined by Maria Arregui, Ph.D. Assistant Director, Evidence...

Andrew Purchase, Director of Pharmacovigilance & Patient Safety and UK QPPV at ICON sat down with...

As the Director of Consulting Operations for Maple Health Group, I conduct both targeted and...

At our recent webinar, we were joined by Dr. Shirley Sylvester, Therapeutic Area Medical Affairs...

In our most recent webinar, DistillerSR customers Christa Goode, Director of Clinical and Medical...

DistillerSR is excited to join ISPOR 2022! This will be our first in-person conference since 2019...

Dual independent screening in your systematic review process is undoubtedly considered a best...

At our session at MedTech Summit 2021, we were joined by Sara Garbin, Senior Clinical Development...

The introduction of new guidelines for the diagnostics industry, outlined by the In-Vitro...

A presentation at the Medical Librarian Association’s 2021 virtual conference brought together...

Introduction

On May 26, 2021, the European Union Medical Device Regulation (EU) 2017/745 (otherwise...

Our clients screen over 50,000 references every day – over 4 million in total to date – and have...

We are currently living through an unprecedented global pandemic. All of our lives are impacted by...